NIH-funded study finds protective effect strongest in women over age 25.
Woman holding the dapivirine vaginal ring tested in the NIH-funded ASPIRE study. International Partnership for Microbicides
Bethesda, Maryland–(ENEWSPF)–February 23, 2016. A ring that continuously releases an experimental antiretroviral drug in the vagina safely provided a modest level of protection against HIV infection in women, a large clinical trial in four sub-Saharan African countries has found. The ring reduced the risk of HIV infection by…
